Trial Investigating the Effect of Semaglutide on Energy Intake, Appetite Sensations, Postprandial Glucose and Triglyceride Metabolism and Gastric Emptying in Obese Subjects Compared With Placebo
Clinical trial NCT02079870 · COMPLETED
Trial details
- NCT number
- NCT02079870
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-06
- Primary completion
- 2015-01-07
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.